Found 18 matching trials
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
PHASE2The purpose of this study is to establish a prospective, single-center plat...
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
PHASE2This study aims to evaluate the efficacy and safety of pyrotinib in combina...
Status
Active Not Recruiting
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
PHASE1This study was designed to evaluate the efficacy and safety of pyrotinib co...
Location
West China Hospital, Sichuan University
Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis
PHASE2The purpose of this study is to assess the efficacy and safety of pyrotinib...
Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer
PHASE2Breast cancer is kind of highly heterogeneous tumor. The patients with the ...
Location
JiangSu Province Hospital/ The First Affiliated Hospital of Nanjing Medical University
Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial
PHASE3The goal of this multicentre, randomized, double-blind controlled, phase II...
Location
Sun Yat-sen Memorial Hospital,Sun Yat-sen University
A Study of Neoadjuvant TCHpy(Pyrotinib ,Trastuzumab,Carboplatin and Paclitaxel)for ER+/HER2+ Breast Cancer
PHASE2This study is a multicenter, single-arm, prospective, open clinical study t...
TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)
PHASE2This is a prospective, randomized, 2-arm, Phrase 2, superiority and multice...
Location
Peking University International Hospital
Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer
PHASE2This is a single-arm, multicenter clinical study designed to evaluate the e...
Location
The Fourth Hospital of Hebei Medical University
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
PHASE3This is an open, prospective and interventional clinical study. Patients wi...
Location
The First Affiliated Hospital of Xi'an Jiaotong University